Prosthetic OEMs and prosthetists who develop custom carbon fiber components encounter a consistent problem: the manufacturing challenge is not simply producing a part from carbon fiber, it is producing a part with the specific geometry, fiber architecture, and structural performance the device requires, repeatedly, under a quality system that meets the regulatory requirements of the medical device market. Regulated prosthetic programs require process discipline, traceability, and documentation depth that go beyond what general commercial composite programs typically demand, and the gap between those requirements is where program risk tends to accumulate.
Working with a manufacturer who has operated as an FDA-registered composite manufacturer since 1985, within an ISO 13485-compliant quality management system, with in-house tooling fabrication and vertically integrated design-through-production capability, means the quality infrastructure and engineering depth are already in place for custom prosthetic programs from prototype through production. Contact our engineering team through our contact page or call 949-361-7580 to discuss your prosthetics manufacturing program.
Carbon fiber composite offers a combination of properties that make it particularly well suited to prosthetic component manufacturing. Its high strength-to-weight ratio allows prosthetic structures to be built with the load-bearing capacity required for active use at a fraction of the weight of metal alternatives. Its stiffness can be tuned through fiber orientation and layup architecture to match the specific flex and energy-return requirements of different prosthetic applications, from high-activity running blades to load-bearing structural sockets. Its corrosion resistance and biocompatibility make it appropriate for the exposure conditions prosthetic devices encounter in daily use. Its formability allows complex anatomical geometries to be produced without the machining constraints that limit metal fabrication. CMI uses high-performance composite materials to create designs with exceptional strength-to-weight ratios, superior stiffness, and outstanding corrosion resistance, as confirmed on our company homepage. Contact our engineering team through our contact page to discuss material selection for your specific prosthetic component application.
CMI’s carbon fiber prosthetics manufacturing capability supports a range of component types and program structures for prosthetic OEMs, prosthetists, and medical device companies developing carbon fiber prosthetic products. Component types include:
Program structures range from build-to-print production of established designs under a formal quality agreement, to design-assist programs where CMI’s engineering team contributes to the design-for-manufacturability review before tooling commitment, to prototype-to-production programs that move from initial proof-of-concept tooling through first article to volume production. The specific program structure, quality system scope, and documentation deliverables are confirmed at intake based on the device regulatory classification and the OEM’s requirements. More detail on how CMI structures program intake is available on our program timeline page.
Custom prosthetic components require a tight feedback loop between design intent and manufacturing outcome, and vertically integrated capability is well positioned to provide it. When the engineers who design the tooling work alongside the fabricators who build it, as they do at CMI, the dimensional translation from design to tool to part is governed by direct communication rather than interpreted documentation. This matters particularly for anatomical components where geometry is patient-specific and dimensional conformance directly affects fit and function. CMI handles design, prototyping, and manufacturing in-house, as confirmed on our custom composite engineering page. The vertically integrated capability spans CAD/CAM/CIM design through stress analysis, mold design, in-house tool fabrication, composite lay-up and cure, CNC machining of composites and metals, assembly, and quality inspection. This integration allows components to be designed specifically for their intended application from the beginning, which can help reduce delays and additional costs that arise when design and manufacturing are managed separately. More detail on our in-house tooling and design capability is available on our in-house design and engineering page.
CMI is an FDA-registered manufacturer operating within an ISO 13485-compliant quality management system. As of February 2, 2026, the FDA’s QMSR incorporated ISO 13485:2016 by reference into 21 CFR Part 820 as the quality system standard for finished medical device manufacturers. FDA has stated that QMSR applies to finished-device manufacturers and certain components that qualify as finished-device accessories — not automatically to every component supplier. CMI’s ISO 13485-compliant quality system aligns with the same standard that now governs finished-device OEMs, supporting alignment across the supply chain for programs where quality agreement requirements extend ISO 13485 obligations to component suppliers. CMI’s quality system aligns with this updated regulatory framework. For prosthetic OEMs evaluating CMI as a manufacturing partner, this alignment means the quality system governing CMI’s production is structured around the same regulatory standard that governs the OEM’s own compliance obligations. The specific scope of quality system controls applied to a prosthetics program varies based on the device classification and the OEM’s quality agreement requirements, and is confirmed at program intake. Contact our engineering team through our contact page to discuss the regulatory scope for your prosthetic component program.
CMI’s four decades of FDA-registered medical composite manufacturing experience, ISO 13485-compliant quality system, and vertically integrated design-through-production capability are structured around the exact requirements custom carbon fiber prosthetic programs impose. Whether the program is a build-to-print production engagement for an established prosthetic OEM or a prototype-to-production development program for a new prosthetic device, the starting point is the same: a conversation with our engineering team about the device, the regulatory context, and the production requirements. Contact our engineering team through our contact page or call 949-361-7580 to begin that conversation, or review our broader medical composite manufacturing capabilities on our medical manufacturing page and our composite solutions page.
.
